These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 17068829)
1. Gene therapy. An ethical profile of a new medical territory. Fuchs M J Gene Med; 2006 Nov; 8(11):1358-62. PubMed ID: 17068829 [TBL] [Abstract][Full Text] [Related]
3. Accidental germ-line modifications through somatic cell gene therapies: some ethical considerations. Kaplan JM; Roy I Am J Bioeth; 2001; 1(4):W13. PubMed ID: 12862004 [TBL] [Abstract][Full Text] [Related]
4. Ethical aspects of clinical trials in gene therapy. Pandya SK Issues Med Ethics; 2000; 8(4):122-4. PubMed ID: 16323376 [No Abstract] [Full Text] [Related]
5. Displaced agendas: current regulatory strategies for germline gene therapy. Marden E; Nelkin D McGill Law J; 2000 May; 45(2):461-81. PubMed ID: 12688283 [TBL] [Abstract][Full Text] [Related]
6. Are contemporary methods for somatic gene therapy suitable for clinical applications? Ledley FD Clin Invest Med; 1993 Feb; 16(1):78-88. PubMed ID: 8467582 [TBL] [Abstract][Full Text] [Related]
7. Ethical, social and public awareness issues in gene therapy EuropaBio. EuropaBio. Working Group on Gene Therapy J Biolaw Bus; 2002; 5(2):59-62. PubMed ID: 12739548 [TBL] [Abstract][Full Text] [Related]
8. Assessing and communicating the risks and benefits of gene transfer clinical trials. Kim SY Curr Opin Mol Ther; 2006 Oct; 8(5):384-9. PubMed ID: 17078380 [TBL] [Abstract][Full Text] [Related]
9. On the scientific and ethical issues of fetal somatic gene therapy. Coutelle C; Rodeck C Gene Ther; 2002 Jun; 9(11):670-3. PubMed ID: 12032684 [TBL] [Abstract][Full Text] [Related]
10. Cell-based interventions for neurologic conditions: ethical challenges for early human trials. Mathews DJ; Sugarman J; Bok H; Blass DM; Coyle JT; Duggan P; Finkel J; Greely HT; Hillis A; Hoke A; Johnson R; Johnston M; Kahn J; Kerr D; Kurtzberg J; Liao SM; McDonald JW; McKhann G; Nelson KB; Rao M; Regenberg A; Siegel AW; Smith K; Solter D; Song H; Vescovi A; Young W; Gearhart JD; Faden R Neurology; 2008 Jul; 71(4):288-93. PubMed ID: 18463365 [TBL] [Abstract][Full Text] [Related]
11. Designing babies: human research issues. Dresser R IRB; 2004; 26(5):1-8. PubMed ID: 15658011 [No Abstract] [Full Text] [Related]
12. Fetal gene therapy: opportunities and risks. Wagner AM; Schoeberlein A; Surbek D Adv Drug Deliv Rev; 2009 Aug; 61(10):813-21. PubMed ID: 19426772 [TBL] [Abstract][Full Text] [Related]
16. The ethics of gene therapy: balancing the risks. Deakin CT; Alexander IE; Kerridge I Curr Opin Mol Ther; 2010 Oct; 12(5):578-85. PubMed ID: 20886390 [TBL] [Abstract][Full Text] [Related]
17. Risks, benefits and ethical, legal, and societal considerations for translation of prenatal gene therapy to human application. Coutelle C; Ashcroft R Methods Mol Biol; 2012; 891():371-87. PubMed ID: 22648781 [TBL] [Abstract][Full Text] [Related]
18. [Gene therapy: ethical aspects and problems of genetic safety]. Zelenin AV Genetika; 1999 Dec; 35(12):1605-12. PubMed ID: 10687090 [TBL] [Abstract][Full Text] [Related]
19. [Scientific ethics of gene therapy for individuals. The urgency for DNA gene surgery]. Valenzuela CY Rev Med Chil; 2003 Oct; 131(10):1208-14. PubMed ID: 14692314 [TBL] [Abstract][Full Text] [Related]
20. Gene therapy progress and prospects: bringing gene therapy into medical practice: the evolution of international ethics and the regulatory environment. Spink J; Geddes D Gene Ther; 2004 Nov; 11(22):1611-6. PubMed ID: 15385950 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]